49 related articles for article (PubMed ID: 740684)
1. Does long term haemofiltration provoke secondary hyperparathyroidism?
Schneider H; Streicher E; Schmidt-Gayk H; Bosnjakovic S
Proc Eur Dial Transplant Assoc; 1978; 15():532-9. PubMed ID: 740684
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Dietary calcium deprivation and secondary hyperparathyroidism in patients treated with chronic dialysis.
Popovtzer MM; Michael UF; Johnson-Dial KS; Ronstadt C; Nelson D; Ogden DA
Miner Electrolyte Metab; 1986; 12(5-6):298-302. PubMed ID: 3807827
[TBL] [Abstract][Full Text] [Related]
4. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
Yendt ER; Kovacs KA; Jones G
Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
[TBL] [Abstract][Full Text] [Related]
5. Chronotherapy of high-dose 1,25-dihydroxyvitamin D3 in hemodialysis patients with secondary hyperparathyroidism: a single-dose study.
Tsuruoka S; Sugimoto K; Ohmori M; Kawaguchi A; Saito T; Fujimura A
Clin Pharmacol Ther; 1999 Dec; 66(6):609-16. PubMed ID: 10613617
[TBL] [Abstract][Full Text] [Related]
6. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
Malluche HH; Ritz E
MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
[No Abstract] [Full Text] [Related]
7. Treatment of hyperparathyroidism--why is it crucial to control serum phosphate?
Brancaccio D; Gallieni M; Cozzolino M
Nephrol Dial Transplant; 1996 Mar; 11(3):420-3. PubMed ID: 8671808
[No Abstract] [Full Text] [Related]
8. Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
Cibulka R; Racek J; Pikner R; Rajdl D; Trefil L; Vesela E; Studenovska M; Siroka R
Calcif Tissue Int; 2007 Aug; 81(2):99-106. PubMed ID: 17622482
[TBL] [Abstract][Full Text] [Related]
9. Hyperparathyroidism in renal failure.
Br Med J; 1978 Feb; 1(6110):390-1. PubMed ID: 624024
[No Abstract] [Full Text] [Related]
10. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature.
Jin J; Robinson AV; Hallowell PT; Jasper JJ; Stellato TA; Wilhem SM
Surgery; 2007 Dec; 142(6):914-20; discussion 914-20. PubMed ID: 18063076
[TBL] [Abstract][Full Text] [Related]
11. Secondary hyperparathyroidism in patients on maintenance hemodialysis.
Hida M
Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198
[TBL] [Abstract][Full Text] [Related]
12. [Kinetic of calcium, phosphate, magnesium and PTH variations during hemodiafiltration].
Rius A; Hernández-Jaras J; Pons R; García Pérez H; Torregrosa E; Sánchez Canel JJ; Fenollosa MA; Pin MT; Tamarit E; Calvo C
Nefrologia; 2007; 27(5):593-8. PubMed ID: 18045035
[TBL] [Abstract][Full Text] [Related]
13. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
14. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients.
Chapuy MC; Chapuy P; Thomas JL; Hazard MC; Meunier PJ
Rev Rhum Engl Ed; 1996 Feb; 63(2):135-40. PubMed ID: 8689285
[TBL] [Abstract][Full Text] [Related]
15. Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism.
Kazama JJ; Gejyo F; Shigematsu T; Fukagawa M
Ther Apher Dial; 2005 Aug; 9(4):328-30. PubMed ID: 16076376
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of progressive secondary hyperparathyroidism in advanced renal failure.
Johnson WJ; Goldsmith RS; Arnaud CD
Med Clin North Am; 1972 Jul; 56(4):961-75. PubMed ID: 4556132
[No Abstract] [Full Text] [Related]
17. [Metastatic calcinosis in patients on long-term dialysis].
Janda J; Sefrna F; Zichová M
Cesk Patol; 1987 Dec; 23(4):204-10. PubMed ID: 3442839
[No Abstract] [Full Text] [Related]
18. [Phosphate binding therapy].
Kinugasa E; Ito H
Nihon Rinsho; 2004 May; 62 Suppl 5():379-83. PubMed ID: 15197949
[No Abstract] [Full Text] [Related]
19. Phosphorus kinetics during haemodialysis and haemofiltration.
Pogglitsch H; Petek W; Ziak E; Sterz F; Holzer H
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():461-8. PubMed ID: 3991541
[TBL] [Abstract][Full Text] [Related]
20. [Complications of dialysis].
Hirasawa Y
Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1532-7. PubMed ID: 8537763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
